BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7915092)

  • 21. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.
    Galimberti S; Guerrini F; Carulli G; Fazzi R; Palumbo GA; Morabito F; Petrini M
    Eur J Haematol; 2004 Jan; 72(1):45-51. PubMed ID: 14962262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDR-1 expression in metastatic malignant melanoma.
    Levine EA; Holzmayer TA; Roninson IB; Das Gupta TK
    J Surg Res; 1993 Jun; 54(6):621-4. PubMed ID: 8105147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of the multidrug resistance P-glycoprotein in high-risk myelodysplasia is associated with immature phenotype.
    Sonneveld P; van Dongen JJ; Hagemeijer A; van Lom K; Nooter K; Schoester M; Adriaansen HJ; Tsuruo T; de Leeuw K
    Leukemia; 1993 Jul; 7(7):963-9. PubMed ID: 8100604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDR1 gene expression in primary and advanced breast cancer.
    Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
    Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia.
    Zöchbauer S; Gsur A; Brunner R; Kyrle PA; Lechner K; Pirker R
    Leukemia; 1994 Jun; 8(6):974-7. PubMed ID: 7516030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control study.
    Björk J; Johansson B; Broberg K; Albin M
    Leuk Res; 2009 Jun; 33(6):788-91. PubMed ID: 19019430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia.
    Pinheiro RF; de Sá Moreira E; Silva MR; Alberto FL; Chauffaille Mde L
    Cancer Genet Cytogenet; 2008 Jun; 183(2):89-93. PubMed ID: 18503825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphoinositide phospholipase Cbeta1 (PI-PLCbeta1) gene in myelodysplastic syndromes and cytogenetically normal acute myeloid leukemia: not a deletion, but increased PI-PLCbeta1 expression is an independent prognostic factor.
    Damm F; Lange K; Heuser M; Oberacker T; Morgan M; Wagner K; Krauter J; Schlegelberger B; Ganser A; Göhring G
    J Clin Oncol; 2010 Aug; 28(22):e384-7; author reply e388-9. PubMed ID: 20516454
    [No Abstract]   [Full Text] [Related]  

  • 30. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
    Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
    Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
    van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
    Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B; Rödjer S; Westin J
    Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
    Ibrahim S; Estey EH; Pierce S; Glassman A; Keating M; O'Brien S; Kantarjian HM; Albitar M
    Am J Clin Pathol; 2000 Nov; 114(5):793-7. PubMed ID: 11068555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
    Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
    Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of multidrug resistance markers, P-glycoprotein and mdr1 mRNA, in human leukemia cells.
    Tsuruo T; Sugimoto Y; Hamada H; Roninson I; Okumura M; Adachi K; Morishima Y; Ohno R
    Jpn J Cancer Res; 1987 Dec; 78(12):1415-9. PubMed ID: 2892823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
    Willman CL
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes.
    Schildgen V; Wulfert M; Gattermann N
    Exp Hematol; 2011 Jun; 39(6):666-675.e1. PubMed ID: 21447369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells.
    Crouthamel MH; Wu D; Yang Z; Ho RJ
    J Pharm Sci; 2006 Dec; 95(12):2767-77. PubMed ID: 16917872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.